During the past decade, Kaiser Franz Josef Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Franz Josef Hospital" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials, followed by "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Medical University of Vienna" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Franz Josef Hospital" #1 collaborator was "Medical University of Vienna" with 2 trials as a collaborator, "Austrian Society Of Surgical Oncology" with 1 trials as a collaborator, "Barmherzige Brüder Vienna" with 1 trials as a collaborator, "Centre Hospitalier Régional de la Citadelle" with 1 trials as a collaborator and "Centre Hospitalier Universitaire Mons" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Franz Josef Hospital" are "Brain and Central Nervous System Tumors" (4 trials), "Metastatic Colorectal Cancer" (3 trials), "COVID-19" (2 trials), "Covid19" (2 trials) and "Glioblastoma Multiforme" (2 trials). Many other conditions were trialed in "Kaiser Franz Josef Hospital" in a lesser frequency.

Most popular intervention types in "Kaiser Franz Josef Hospital" are "Drug" (24 trials), "Other" (6 trials), "Device" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials), "5-Fluoruracil, Cisplatinum" (1 trials) and "Apremilast 20mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Franz Josef Hospital" are 26 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Kaiser Franz Josef Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Kaiser Franz Josef Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Franz Josef Hospital, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".